# Onterris, Inc.: financial statements, quarterly

ONT · NYSE · CIK 1643615 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ont.md) · [Financials](/companies/ont/financials.md) · [Filings](/companies/ont/filings.md) · [Insiders](/companies/ont/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ont/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [168](/filings/0000950170-24-123240.md) | [166 d](/filings/0001193125-26-076511.md) | [155](/filings/0000950170-25-066887.md) | [173](/filings/0000950170-25-104954.md) | [179](/filings/0001193125-25-266839.md) | [189 d](/filings/0001193125-26-076511.md) | [178](/filings/0001193125-26-211815.md) | [235](/filings/0001193125-26-337925.md) | [225](/filings/0001193125-25-266839.md) | [193 d](/filings/0001193125-26-076511.md) | [169](/filings/0001193125-26-211815.md) | [187](/filings/0001193125-26-337925.md) |
| Cost of revenue | $m | [102](/filings/0000950170-24-123240.md) | [102 d](/filings/0001193125-26-076511.md) | [96.6](/filings/0000950170-25-066887.md) | [104](/filings/0000950170-25-104954.md) | [106](/filings/0001193125-25-266839.md) | [112 d](/filings/0001193125-26-076511.md) | [108](/filings/0001193125-26-211815.md) | [133](/filings/0001193125-26-337925.md) | [136](/filings/0001193125-25-266839.md) | [119 d](/filings/0001193125-26-076511.md) | [101](/filings/0001193125-26-211815.md) | [104](/filings/0001193125-26-337925.md) |
| Selling, general and administrative | $m | [56.9](/filings/0000950170-24-123240.md) | [61.1 d](/filings/0001193125-26-076511.md) | [57.1](/filings/0000950170-25-066887.md) | [59.2](/filings/0000950170-25-104954.md) | [60.9](/filings/0001193125-25-266839.md) | [84.4 d](/filings/0001193125-26-076511.md) | [66.2](/filings/0001193125-26-211815.md) | [73.7](/filings/0001193125-26-337925.md) | [65.7](/filings/0001193125-25-266839.md) | [65.2 d](/filings/0001193125-26-076511.md) | [61.3](/filings/0001193125-26-211815.md) | [63.0](/filings/0001193125-26-337925.md) |
| Operating income | $m | [(3.4)](/filings/0000950170-24-123240.md) | [(8.9) d](/filings/0001193125-26-076511.md) | [(10.1)](/filings/0000950170-25-066887.md) | [(2.7)](/filings/0000950170-25-104954.md) | [(1.2)](/filings/0001193125-25-266839.md) | [(22.8) d](/filings/0001193125-26-076511.md) | [(10.6)](/filings/0001193125-26-211815.md) | [14.9](/filings/0001193125-26-337925.md) | [9.9](/filings/0001193125-25-266839.md) | [(2.6) d](/filings/0001193125-26-076511.md) | [(6.1)](/filings/0001193125-26-211815.md) | [6.5](/filings/0001193125-26-337925.md) |
| Income tax | $m | [1.3](/filings/0000950170-24-123240.md) | [(3.8) d](/filings/0001193125-26-076511.md) | [0.5](/filings/0000950170-25-066887.md) | [2.6](/filings/0000950170-25-104954.md) | [1.4](/filings/0001193125-25-266839.md) | [3.5 d](/filings/0001193125-26-076511.md) | [2.9](/filings/0001193125-26-211815.md) | [1.0](/filings/0001193125-26-337925.md) | [7.3](/filings/0001193125-25-266839.md) | [0.9 d](/filings/0001193125-26-076511.md) | [2.3](/filings/0001193125-26-211815.md) | [0.3](/filings/0001193125-26-337925.md) |
| Net income | $m | [(7.5)](/filings/0000950170-24-123240.md) | [(1.4) d](/filings/0001193125-26-076511.md) | [(13.4)](/filings/0001193125-25-266839.md) | [(10.2)](/filings/0001193125-25-266839.md) | [(10.6)](/filings/0001193125-25-266839.md) | [(28.2) d](/filings/0001193125-26-076511.md) | [(19.4)](/filings/0001193125-26-337925.md) | [18.4](/filings/0001193125-26-337925.md) | [8.4](/filings/0001193125-25-266839.md) | [(8.2) d](/filings/0001193125-26-076511.md) | [(12.7)](/filings/0001193125-26-337925.md) | [1.4](/filings/0001193125-26-337925.md) |
| Diluted EPS | $ per share | [(0.39)](/filings/0000950170-24-123240.md) | not reported | [(0.53)](/filings/0000950170-25-066887.md) | [(0.39)](/filings/0000950170-25-104954.md) | [(0.39)](/filings/0001193125-25-266839.md) | not reported | [(0.64)](/filings/0001193125-26-211815.md) | [0.42](/filings/0001193125-26-337925.md) | [0.21](/filings/0001193125-25-266839.md) | not reported | [(0.35)](/filings/0001193125-26-211815.md) | [0.04](/filings/0001193125-26-337925.md) |
| Basic EPS | $ per share | [(0.39)](/filings/0000950170-24-123240.md) | not reported | [(0.53)](/filings/0000950170-25-066887.md) | [(0.39)](/filings/0000950170-25-104954.md) | [(0.39)](/filings/0001193125-25-266839.md) | not reported | [(0.64)](/filings/0001193125-26-211815.md) | [0.48](/filings/0001193125-26-337925.md) | [0.24](/filings/0001193125-25-266839.md) | not reported | [(0.35)](/filings/0001193125-26-211815.md) | [0.04](/filings/0001193125-26-337925.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [23.2](/filings/0000950170-23-061070.md) | [23.2](/filings/0000950170-25-030806.md) | [9.5](/filings/0000950170-24-055584.md) | [16.9](/filings/0000950170-24-092715.md) | [13.0](/filings/0000950170-24-123240.md) | [12.9](/filings/0001193125-26-076511.md) | [30.3](/filings/0000950170-25-066887.md) | [10.5](/filings/0000950170-25-104954.md) | [6.7](/filings/0001193125-25-266839.md) | [11.2](/filings/0001193125-26-337925.md) | [10.0](/filings/0001193125-26-211815.md) | [12.7](/filings/0001193125-26-337925.md) |
| Current assets | $m | [213](/filings/0000950170-23-061070.md) | [201](/filings/0000950170-25-030806.md) | [204](/filings/0000950170-24-055584.md) | [240](/filings/0000950170-24-092715.md) | [247](/filings/0000950170-24-123240.md) | [238](/filings/0001193125-26-076511.md) | [249](/filings/0000950170-25-066887.md) | [261](/filings/0000950170-25-104954.md) | [256](/filings/0001193125-25-266839.md) | [240](/filings/0001193125-26-337925.md) | [217](/filings/0001193125-26-211815.md) | [238](/filings/0001193125-26-337925.md) |
| Total assets | $m | [836](/filings/0000950170-23-061070.md) | [817](/filings/0000950170-25-030806.md) | [918](/filings/0000950170-24-055584.md) | [944](/filings/0000950170-24-092715.md) | [1,007](/filings/0000950170-24-123240.md) | [990](/filings/0001193125-26-076511.md) | [992](/filings/0000950170-25-066887.md) | [998](/filings/0000950170-25-104954.md) | [986](/filings/0001193125-25-266839.md) | [981](/filings/0001193125-26-337925.md) | [948](/filings/0001193125-26-211815.md) | [967](/filings/0001193125-26-337925.md) |
| Current liabilities | $m | [135](/filings/0000950170-23-061070.md) | [126](/filings/0000950170-25-030806.md) | [125](/filings/0000950170-24-055584.md) | [132](/filings/0000950170-24-092715.md) | [128](/filings/0000950170-24-123240.md) | [159](/filings/0001193125-26-076511.md) | [122](/filings/0000950170-25-066887.md) | [147](/filings/0000950170-25-104954.md) | [154](/filings/0001193125-25-266839.md) | [168](/filings/0001193125-26-337925.md) | [118](/filings/0001193125-26-211815.md) | [119](/filings/0001193125-26-337925.md) |
| Total liabilities | $m | [368](/filings/0000950170-23-061070.md) | [343](/filings/0000950170-25-030806.md) | [501](/filings/0000950170-24-055584.md) | [402](/filings/0000950170-24-092715.md) | [465](/filings/0000950170-24-123240.md) | [451](/filings/0001193125-26-076511.md) | [455](/filings/0000950170-25-066887.md) | [494](/filings/0000950170-25-104954.md) | [527](/filings/0001193125-25-266839.md) | [530](/filings/0001193125-26-337925.md) | [508](/filings/0001193125-26-211815.md) | [537](/filings/0001193125-26-337925.md) |
| Long-term debt | $m | [153](/filings/0000950170-23-061070.md) | [149](/filings/0000950170-25-030806.md) | [281](/filings/0000950170-24-055584.md) | [189](/filings/0000950170-24-092715.md) | [233](/filings/0000950170-24-123240.md) | [205](/filings/0001193125-26-076511.md) | [236](/filings/0000950170-25-066887.md) | [265](/filings/0000950170-25-104954.md) | [302](/filings/0001193125-25-266839.md) | [277](/filings/0001193125-26-337925.md) | [310](/filings/0001193125-26-211815.md) | [338](/filings/0001193125-26-337925.md) |
| Current portion of debt | $m | [14.2](/filings/0000950170-23-061070.md) | [14.2](/filings/0000950170-25-030806.md) | [16.7](/filings/0000950170-24-055584.md) | [23.7](/filings/0000950170-24-092715.md) | [16.8](/filings/0000950170-24-123240.md) | [17.9](/filings/0001193125-26-076511.md) | [6.2](/filings/0000950170-25-066887.md) | [8.7](/filings/0000950170-25-104954.md) | [11.2](/filings/0001193125-25-266839.md) | [11.2](/filings/0001193125-26-337925.md) | [11.3](/filings/0001193125-26-211815.md) | [11.3](/filings/0001193125-26-337925.md) |
| Shareholders' equity | $m | [315](/filings/0000950170-24-123240.md) | [321](/filings/0001193125-26-076511.md) | [324](/filings/0001193125-25-266839.md) | [449](/filings/0001193125-25-266839.md) | [449](/filings/0001193125-25-266839.md) | [446](/filings/0001193125-26-337925.md) | [444](/filings/0001193125-26-337925.md) | [470](/filings/0001193125-26-337925.md) | [459](/filings/0001193125-25-266839.md) | [451](/filings/0001193125-26-337925.md) | [440](/filings/0001193125-26-337925.md) | [430](/filings/0001193125-26-337925.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [17.0 d](/filings/0000950170-24-123240.md) | [14.6 d](/filings/0001193125-26-076511.md) | [(22.0)](/filings/0000950170-25-066887.md) | [0.9 d](/filings/0000950170-25-104954.md) | [11.4 d](/filings/0001193125-25-266839.md) | [32.0 d](/filings/0001193125-26-076511.md) | [5.5](/filings/0001193125-26-211815.md) | [21.9 d](/filings/0001193125-26-337925.md) | [28.2 d](/filings/0001193125-25-266839.md) | [51.9 d](/filings/0001193125-26-076511.md) | [(11.6)](/filings/0001193125-26-211815.md) | [6.2 d](/filings/0001193125-26-337925.md) |
| Capital expenditure | $m | [4.0 d](/filings/0000950170-24-123240.md) | [4.6 d](/filings/0001193125-26-076511.md) | [7.3](/filings/0000950170-25-066887.md) | [10.6 d](/filings/0000950170-25-104954.md) | [1.2 d](/filings/0001193125-25-266839.md) | [2.2 d](/filings/0001193125-26-076511.md) | [3.2](/filings/0001193125-26-211815.md) | [2.0 d](/filings/0001193125-26-337925.md) | [5.8 d](/filings/0001193125-25-266839.md) | [5.4 d](/filings/0001193125-26-076511.md) | [5.7](/filings/0001193125-26-211815.md) | [5.7 d](/filings/0001193125-26-337925.md) |
| Dividends paid | $m | [4.1 d](/filings/0000950170-24-123240.md) | [4.1 d](/filings/0001193125-26-076511.md) | not reported | not reported | [2.8 d](/filings/0001193125-25-266839.md) | [2.8 d](/filings/0001193125-26-076511.md) | [2.8](/filings/0001193125-26-211815.md) | [0.0 d](/filings/0001193125-26-337925.md) | [1.4 d](/filings/0001193125-25-266839.md) | [0.0 d](/filings/0001193125-26-076511.md) | [0.0](/filings/0001193125-26-211815.md) | [0.0 d](/filings/0001193125-26-337925.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [10.0](/filings/0001193125-26-211815.md) | [20.0 d](/filings/0001193125-26-337925.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [29.7](/filings/0000950170-23-061070.md) | [29.9](/filings/0000950170-24-055584.md) | [30.0](/filings/0000950170-24-092715.md) | [30.1](/filings/0000950170-24-123240.md) | [30.4](/filings/0000950170-25-066887.md) | [33.3](/filings/0000950170-25-104954.md) | [34.2](/filings/0001193125-25-266839.md) | [34.5](/filings/0001193125-26-211815.md) | [43.5](/filings/0001193125-26-337925.md) | [39.9](/filings/0001193125-25-266839.md) | [36.0](/filings/0001193125-26-211815.md) | [38.7](/filings/0001193125-26-337925.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 35,117,424 at 2026-07-31, from the cover of the [10-Q filed 2026-08-06](/filings/0001193125-26-337925.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:45 ET. No prices; not investment advice.